Clinical Trial: FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT07509398) titled 'FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer' on March 29.

Brief Summary: This clinical trial evaluates the efficacy and safety of adding fecal microbiota transplantation (FMT) to first-line standard of care for patients with initially unresectable colorectal cancer (CRC).

FMT is an established procedure designed to restore intestinal microbiome homeostasis by transferring processed fecal microbiota from a rigorously screened healthy donor into the patient's gastrointestinal tract. The standard first-line treatment regimen typically consists of chemotherapy, with or without targeted ther...